Evolving Considerations in the Treatment of Metastatic Head and Neck Squamous Cell Carcinoma: A Closer Look at the Role of Immunotherapy.
Immunotherapy is a dramatic advance in the treatment of metastatic head and neck squamous cell carcinoma. Checkpoint inhibitors are improving survival in patients with late-stage disease and are moving into earlier lines of therapy.
| Published in: | Journal of Managed Care Medicine Vol. 22; no. 4; pp. 55 - 59 |
|---|---|
| Main Author: | |
| Format: | CEU pictorial tables/charts Journal Article |
| Published: |
National Association of Managed Care Physicians, Inc.
2019
|
| Online Access: | View this record in EBSCOhost |